Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of four antibiotics and antibiotic adjuncts: - **Penicillin** is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. - **Ampicillin** is an aminopenicillin, also a beta-lactam antibiotic, with activity against both Gram-positive and some Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis. - **Sulbactam** is a beta-lactamase inhibitor that protects beta-lactam antibiotics (like ampicillin) from degradation by bacterial enzymes called beta-lactamases. Sulbactam itself has limited antibacterial activity but enhances the efficacy of companion antibiotics[5][6][7]. - **Cefuroxime** is a second-generation cephalosporin (beta-lactam) antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria. It resists many common beta-lactamases[8]. The combination would theoretically provide very broad coverage for various bacterial infections, including those caused by organisms producing beta-lactamase enzymes. However, there are no known approved or marketed products containing all four agents together; combinations such as ampicillin/sulbactam or cefuroxime alone are used in clinical practice[2][3][4]. The mechanism of action for each component involves inhibition of bacterial cell wall synthesis (for penicillins/cephalosporins), while sulbactam acts as an enzyme inhibitor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on penicillin + ampicillin + sulbactam + cefuroxime.